The United States Liquid Biopsy Market Report 2023, provided by Astute Analytica, offers an extensive analysis of the market’s technical and financial data for both the present and foreseeable future. This report serves as a valuable addition to the market research archive, providing a thorough investigation and analysis of crucial aspects of the United States Liquid Biopsy Market.
A request of this Sample PDF File@- https://www.astuteanalytica.com/request-sample/united-states-liquid-biopsy-market
The United States liquid biopsy market was valued at US$ 3,405.8 million in 2022 and is projected to surpass the market valuation of US$ 10,798 million by 2031 at a CAGR of 13.68% during the forecast period 2023–2031. It analyses the market’s regional trends, size, expansion prospects, and important factors in each region. Additionally, it acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. Both the direct and indirect effects of the pandemic on related industries are taken into account and discussed in the report.
The report gives a thorough analysis of the United States Liquid Biopsy Market, covering regional trends, market size, prospects for expansion, and important market factors in each region. In 2021, the United States Gross Domestic Product (GDP) value was US$ 23,315.08 billion, according to verified data from the World Bank. In terms of GDP, the United States accounts for 10.41% of the global economy. The mixed economy of the United States is very advanced. By nominal GDP, it has the largest economy in the world, and by purchasing power parity (PPP), it is second only to China in size.
The leading companies mentioned are
- Biocept, Inc.
- Illumina, Inc.
- Myriad Genetics, Inc.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Guardant Health
- F. Hoffmann-La Roche Ltd
- ANGLE plc
- BIODESIX
- NeoGenomics Laboratories, Inc.
- Other major players
The report also acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. It considers both the direct impact of the pandemic and the indirect influence on related industries. The observations on the pandemic’s impact are included in the report.
Highlights of the Report: | |
| Historic Year | 2018 – 2021 |
| Base Year | 2022 |
| Forecast Year | 2023 – 2031 |
| No of Pages | 91 |
| Total Figures | 30 |
| Total tables | 40 |
The request of this Fuller Report Here@ – https://www.astuteanalytica.com/industry-report/united-states-liquid-biopsy-market
Furthermore, the report divides geographical regions into several major categories for production, consumption, revenue (in US dollars), and market share analysis. It discusses the predicted growth of the market in these regions between 2021 and 2031.
The segmentation overview of the United States Liquid Biopsy Market includes
By Technology
- Multi Gene Parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
By Product
- Blood Sample Based
- Others
By Biomarker
- Circulating Nucleic Acids
- CTC
- Exosomes/Microvesicles
- Circulating Proteins
Overall, Astute Analytica’s report on the United States Liquid Biopsy Market appears to be a comprehensive resource for businesses seeking to understand the current state of the market and its future growth prospects.
Download Sample PDF Report@- https://www.astuteanalytica.com/request-sample/united-states-liquid-biopsy-market
About Astute Analytica:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
Get in touch with us
Phone number: +18884296757
Email: [email protected]
Visit our website: https://www.astuteanalytica.com/
